{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T17:59:55Z","timestamp":1783792795019,"version":"3.55.0"},"reference-count":104,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Rift Valley fever (RVF) is a mosquito-borne viral disease that primarily affects animals, especially ruminants, but has the capacity to infect humans and result in outbreaks. Infection with the causative agent, RVF virus (RVFV), causes severe disease in domestic animals, especially sheep, resulting in fever, anorexia, immobility, abortion, and high morbidity and mortality rates in neonate animals. Humans become infected through exposure to infected animals and, less frequently, directly via a mosquito bite. A greater awareness of RVFV and its epidemic potential has resulted in increased investment in the development of interventions, especially vaccines. There is currently no substitute for the use of animal models in order to evaluate these vaccines. As outbreaks of RVF disease are difficult to predict or model, conducting Phase III clinical trials will likely not be feasible. Therefore, representative animal model systems are essential for establishing efficacy data to support licensure. Nonhuman primate (NHP) species are often chosen due to their closeness to humans, reflecting similar susceptibility and disease kinetics. This review covers the use of NHP models in RVFV research, with much of the work having been conducted in rhesus macaques and common marmosets. The future direction of RVF work conducted in NHP is discussed in anticipation of the importance of it being a key element in the development and approval of a human vaccine.<\/jats:p>","DOI":"10.3390\/pathogens13100856","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T03:57:52Z","timestamp":1727755072000},"page":"856","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Review of Nonhuman Primate Models of Rift Valley Fever Virus Infection: Progress, Challenge Strains, and Future Directions"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-076X","authenticated-orcid":false,"given":"Kimimuepigha","family":"Ebisine","sequence":"first","affiliation":[{"name":"UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8128-9674","authenticated-orcid":false,"given":"Darcy","family":"Quist","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6805-2574","authenticated-orcid":false,"given":"Stephen","family":"Findlay-Wilson","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3632-6163","authenticated-orcid":false,"given":"Emma","family":"Kennedy","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Dowall","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"001893","DOI":"10.1099\/jgv.0.001893","article-title":"ICTV Virus Taxonomy Profile: Phenuiviridae 2023","volume":"104","author":"Sasaya","year":"2023","journal-title":"J. Gen. Virol."},{"key":"ref_2","unstructured":"Granoff, A., and Webster, R.G. (1999). BUNYAVIRIDAE|General Features. Encyclopedia of Virology, Elsevier. [2nd ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Nicoletti, L. (2014). Rift Valley Fever and Other Phleboviruses (Bunyaviridae). Reference Module in Biomedical Sciences, Elsevier.","DOI":"10.1016\/B978-0-12-801238-3.02660-X"},{"key":"ref_4","unstructured":"Mahy, B.W.J., and Van Regenmortel, M.H.V. (2008). Rift Valley Fever and Other Phleboviruses. Encyclopedia of Virology, Academic Press. [3rd ed.]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from east africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gachohi, J.M., Njenga, M.K., Kitala, P., and Bett, B. (2016). Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0005049"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/vbz.2018.2357","article-title":"Human Cases of Rift Valley Fever in South Africa, 2018","volume":"18","author":"Kgaladi","year":"2018","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Maluleke, M.R., Phosiwa, M., van Schalkwyk, A., Michuki, G., Lubisi, B.A., Kegakilwe, P.S., Kemp, S.J., and Majiwa, P.A.O. (2019). A comparative genome analysis of Rift Valley Fever virus isolates from foci of the disease outbreak in South Africa in 2008\u20132010. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0006576"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mroz, C., Gwida, M., El-Ashker, M., El-Diasty, M., El-Beskawy, M., Ziegler, U., Eiden, M., and Groschup, M.H. (2017). Seroprevalence of Rift Valley fever virus in livestock during inter-epidemic period in Egypt, 2014\/15. BMC Vet. Res., 13.","DOI":"10.1186\/s12917-017-0993-8"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Tumusiime, D., Isingoma, E., Tashoroora, O.B., Ndumu, D.B., Bahati, M., Nantima, N., Mugizi, D.R., Jost, C., and Bett, B. (2023). Mapping the risk of Rift Valley fever in Uganda using national seroprevalence data from cattle, sheep and goats. PLoS Negl. Trop. Dis., 17.","DOI":"10.1371\/journal.pntd.0010482"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6559193","DOI":"10.1155\/2022\/6559193","article-title":"Serological Evidence of Antibodies to Rift Valley Fever Virus in Wild and Domestic Animals in Bauchi State, Nigeria","volume":"2022","author":"Atuman","year":"2022","journal-title":"Vet. Med. Int."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jori, F., Alexander, K.A., Mokopasetso, M., Munstermann, S., Moagabo, K., and Paweska, J.T. (2015). Serological Evidence of Rift Valley Fever Virus Circulation in Domestic Cattle and African Buffalo in Northern Botswana (2010\u20132011). Front. Vet. Sci., 2.","DOI":"10.3389\/fvets.2015.00063"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/tbed.13402","article-title":"Seroprevalence of Rift valley fever in South African domestic and wild suids (1999\u20132016)","volume":"67","author":"Lubisi","year":"2020","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.3201\/eid2712.210643","article-title":"Rift Valley Fever Virus Seroprevalence among Humans, Northern KwaZulu-Natal Province, South Africa, 2018\u20132019","volume":"27","author":"Msimang","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105462","DOI":"10.1016\/j.actatropica.2020.105462","article-title":"First serological evidence of the Rift Valley fever Phlebovirus in Tunisian camels","volume":"207","author":"Selmi","year":"2020","journal-title":"Acta Trop."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Trabelsi, M.K., Hachid, A., Derrar, F., Messahel, N.E., Bia, T., Mockbel, Y., Khardine, A.F., Degui, D., Bellout, L., and Benaissa, M.H. (2023). Serological evidence of Rift Valley fever viral infection among camels imported into Southern Algeria. Comp. Immunol. Microbiol. Infect. Dis., 100.","DOI":"10.1016\/j.cimid.2023.102035"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2478\/jvetres-2021-0009","article-title":"Rift Valley Fever\u2014A Growing Threat To Humans and Animals","volume":"65","author":"Rola","year":"2021","journal-title":"J. Vet. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.20506\/rst.18.3.1195","article-title":"An epizootic of Rift Valley fever in Egypt in 1997","volume":"18","author":"Hussein","year":"1999","journal-title":"Rev. Sci. Tech."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Fawzy, M., and Helmy, Y.A. (2019). The One Health Approach is Necessary for the Control of Rift Valley Fever Infections in Egypt: A Comprehensive Review. Viruses, 11.","DOI":"10.3390\/v11020139"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.actatropica.2018.01.015","article-title":"Rift Valley Fever in Egypt and other African countries: Historical review, recent outbreaks and possibility of disease occurrence in Egypt","volume":"181","author":"Kenawy","year":"2018","journal-title":"Acta Trop."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0035-9203(79)90004-X","article-title":"The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizzotic and virological studies","volume":"73","author":"Meegan","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1089\/vbz.2010.0245","article-title":"The status of Rift Valley fever in animals in Saudi Arabia: A mini review","volume":"11","author":"Hussein","year":"2011","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_23","unstructured":"CDC (2000). Outbreak of Rift Valley fever\u2014Saudi Arabia, August\u2013October, 2000. MMWR Morb. Mortal. Wkly. Rep., 49, 905\u2013908."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/iai.33.3.848-853.1981","article-title":"Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus","volume":"33","author":"Brown","year":"1981","journal-title":"Infect. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nmni.2015.10.010","article-title":"Serologic evidence of exposure to Rift Valley fever virus detected in Tunisia","volume":"9","author":"Bosworth","year":"2016","journal-title":"New Microbes New Infect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/0972-9062.225840","article-title":"The first positive serological study on rift valley fever in ruminants of Iran","volume":"54","author":"Fakour","year":"2017","journal-title":"J. Vector Borne Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s11250-017-1359-8","article-title":"The first serological evidence for Rift Valley fever infection in the camel, goitered gazelle and Anatolian water buffaloes in Turkey","volume":"49","author":"Kale","year":"2017","journal-title":"Trop. Anim. Health Prod."},{"key":"ref_28","first-page":"91","article-title":"Seroepidemiology of Rift Valley Fever in Basrah","volume":"3","author":"Muhsen","year":"2012","journal-title":"Kufa J. Vet. Med. Sci."},{"key":"ref_29","first-page":"21","article-title":"Presence of antibodies to Rift Valley fever virus in children, cattle and sheep in Turkey","volume":"6","author":"Yilmaz","year":"2017","journal-title":"J. Virol. Antivir. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJMp2308666","article-title":"Rift Valley Fever\u2014The Need for an Integrated Response","volume":"389","author":"Wandera","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_31","first-page":"908","article-title":"Rift valley fever in South Africa. 2. The occurrence of human cases in the Orange Free State, the North-Western Cape Province, the Western and Southern Transvaal. B. Field and laboratory investigation","volume":"25","author":"Gear","year":"1951","journal-title":"S. Afr. Med. J."},{"key":"ref_32","first-page":"890","article-title":"Rift Valley fever in South Africa: 2. The occurrence of human cases in the Orange Free State, the north-western Cape province, the western and southern Transvaal. A Epidemiological and clinical findings","volume":"25","author":"Joubert","year":"1951","journal-title":"S. Afr. Med. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0035-9203(79)90006-3","article-title":"Epidemic Rift Valley fever in Egypt: Observations of the spectrum of human illness","volume":"73","author":"Laughlin","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.59.3.305","article-title":"Rift valley fever in man: Report of a fatal laboratory infection complicated by thrombophlebitis","volume":"59","author":"Schwentker","year":"1934","journal-title":"J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.17-0104","article-title":"Rift Valley Fever Seroprevalence in Coastal Kenya","volume":"97","author":"Banda","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.14-0575","article-title":"Elevated antibodies against Rift Valley fever virus among humans with exposure to ruminants in Saudi Arabia","volume":"92","author":"Memish","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ayari, R., Chaouch, H., Findlay-Wilson, S., Hachfi, W., Ben Lasfar, N., Bellazreg, F., Dowall, S., Hannachi, N., and Letaief, A. (2024). Seroprevalence and Risk Factors Associated with Phleboviruses and Crimean-Congo Hemorrhagic Fever Virus among Blood Donors in Central Tunisia. Pathogens, 13.","DOI":"10.3390\/pathogens13040348"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/0972-9062.302042","article-title":"Serological evidence of Rift Valley fever virus among humans in Mersin province of Turkey","volume":"56","author":"Kurnaz","year":"2019","journal-title":"J. Vector Borne Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lapa, D., Specchiarello, E., Francalancia, M., Girardi, E., Maggi, F., and Garbuglia, A.R. (2023). Detection of Anti-Rift Valley Fever Virus Antibodies in Serum Samples of Patients with Suspected Arbovirus Infection. Microorganisms, 11.","DOI":"10.3390\/microorganisms11082081"},{"key":"ref_40","unstructured":"World Health Organization (2019). Efficacy Trials of Rift Valley Fever Vaccines and Therapeutics Guidance on Clinical Trial Design, World Health Organization."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s13071-018-2884-7","article-title":"Competence of mosquitoes native to the United Kingdom to support replication and transmission of Rift Valley fever virus","volume":"11","author":"Lumley","year":"2018","journal-title":"Parasit Vectors"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3181\/00379727-64-15803","article-title":"Human Infection with Rift Valley Fever Virus and Immunity Twelve Years After Single Attack","volume":"64","author":"Sabin","year":"1947","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-ento-010715-023819","article-title":"Rift Valley Fever: An Emerging Mosquito-Borne Disease","volume":"61","author":"Linthicum","year":"2016","journal-title":"Annu. Rev. Entomol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: Epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","first-page":"803","article-title":"Rift Valley fever in humans in South Africa","volume":"58","author":"McIntosh","year":"1980","journal-title":"S. Afr. Med. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"100583","DOI":"10.1016\/j.onehlt.2023.100583","article-title":"Rift Valley fever in West Africa: A zoonotic disease with multiple socio-economic consequences","volume":"17","author":"Tinto","year":"2023","journal-title":"One Health"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antiviral Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1016\/j.vaccine.2019.09.009","article-title":"UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments","volume":"37","author":"Noad","year":"2019","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/epirev\/mxz012","article-title":"CEPI: Driving Progress Toward Epidemic Preparedness and Response","volume":"41","author":"Gouglas","year":"2019","journal-title":"Epidemiol. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Gerken, K.N., LaBeaud, A.D., Mandi, H., L\u2019Azou Jackson, M., Breugelmans, J.G., and King, C.H. (2022). Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0009852"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Kitandwe, P.K., McKay, P.F., Kaleebu, P., and Shattock, R.J. (2022). An Overview of Rift Valley Fever Vaccine Development Strategies. Vaccines, 10.","DOI":"10.3390\/vaccines10111794"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Finch, C.L., Dowling, W.E., King, T.H., Martinez, C., Nguyen, B.V., Roozendaal, R., Rustomjee, R., Skiadopoulos, M.H., Vert-Wong, E., and Yellowlees, A. (2022). Bridging Animal and Human Data in Pursuit of Vaccine Licensure. Vaccines, 10.","DOI":"10.3390\/vaccines10091384"},{"key":"ref_53","first-page":"37988","article-title":"New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule","volume":"67","author":"Administration","year":"2002","journal-title":"Fed. Regist."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Graham, V.A., Easterbrook, L., Kennedy, E., Rayner, E., Findlay-Wilson, S., Flett, L., Wise, E.L., Treagus, S., Fotheringham, S., and Kempster, S. (2023). Pathogenesis of Rift Valley Fever Virus in a BALB\/c Mouse Model Is Affected by Virus Culture Conditions and Sex of the Animals. Viruses, 15.","DOI":"10.3390\/v15122369"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Bales, J.M., Powell, D.S., Bethel, L.M., Reed, D.S., and Hartman, A.L. (2012). Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus. Front. Cell. Infect. Microbiol., 2.","DOI":"10.3389\/fcimb.2012.00105"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Scharton, D., Van Wettere, A.J., Bailey, K.W., Vest, Z., Westover, J.B., Siddharthan, V., and Gowen, B.B. (2015). Rift Valley fever virus infection in golden Syrian hamsters. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116722"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.62.3.433","article-title":"Rift valley fever: A report of three cases of laboratory infection and the experimental transmission of the disease to ferrets","volume":"62","author":"Francis","year":"1935","journal-title":"J. Exp. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"10-1128","DOI":"10.1128\/mSphere.00798-20","article-title":"Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret","volume":"5","author":"Barbeau","year":"2020","journal-title":"mSphere"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Xu, Y., Wang, X., Jiang, L., Zhou, Y., Liu, Y., Wang, F., and Zhang, L. (2023). Natural hosts and animal models for Rift Valley fever phlebovirus. Front. Vet. Sci., 10.","DOI":"10.3389\/fvets.2023.1258172"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molimm.2015.02.001","article-title":"Understanding Rift Valley fever: Contributions of animal models to disease characterization and control","volume":"66","author":"Lorenzo","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1644\/06-MAMM-R-422.1","article-title":"Mammal Species of the World: A Taxonomic and Geographic Reference by D. E. Wilson; D. M. Reeder","volume":"88","author":"Solari","year":"2007","journal-title":"J. Mammal."},{"key":"ref_62","unstructured":"Terio, K.A., McAloose, D., and Leger, J.S. (2018). Chapter 14\u2014New World and Old World Monkeys. Pathology of Wildlife and Zoo Animals, Academic Press."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Herron, I.C.T., Laws, T.R., and Nelson, M. (2024). Marmosets as models of infectious diseases. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1340017"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0140-6736(00)99624-7","article-title":"The virus of rift valley fever or enzo\u00f6tic hepatitis","volume":"218","author":"Findlay","year":"1931","journal-title":"Lancet"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0035-9203(32)90042-X","article-title":"Rift valley fever or enzootic hepatitis","volume":"25","author":"Findlay","year":"1932","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_66","first-page":"431","article-title":"Studies on Neurotropic Rift Valley Fever Virus: The Susceptibility of Sheep and Monkeys","volume":"17","author":"Findlay","year":"1936","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_67","first-page":"107","article-title":"Rift Valley fever; isolation of the virus from wild mosquitoes","volume":"29","author":"Smithburn","year":"1948","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/oxfordjournals.aje.a120289","article-title":"Stability and infectivity of airborne yellow fever and rift valley fever viruses","volume":"77","author":"Miller","year":"1963","journal-title":"Am. J. Epidemiol."},{"key":"ref_69","first-page":"65","article-title":"Rift valley fever","volume":"10","author":"Easterday","year":"1965","journal-title":"Adv. Vet. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-3542(86)90024-0","article-title":"Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator","volume":"6","author":"Peters","year":"1986","journal-title":"Antiviral Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01311021","article-title":"Experimental Rift Valley fever in rhesus macaques","volume":"99","author":"Peters","year":"1988","journal-title":"Arch. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"S815","DOI":"10.1093\/clinids\/11.Supplement_4.S815","article-title":"Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha","volume":"11","author":"Morrill","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01311288","article-title":"Pathogenesis of Rift Valley fever in rhesus monkeys: Role of interferon response","volume":"110","author":"Morrill","year":"1990","journal-title":"Arch. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"S807","DOI":"10.1093\/clinids\/11.Supplement_4.S807","article-title":"Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys","volume":"11","author":"Cosgriff","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0923-2516(89)80091-3","article-title":"Rift Valley fever infection of rhesus monkeys: Implications for rapid diagnosis of human disease","volume":"140","author":"Morrill","year":"1989","journal-title":"Res. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/jir.1991.11.297","article-title":"Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey","volume":"11","author":"Morrill","year":"1991","journal-title":"J. Interferon Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/S0264-410X(03)00131-2","article-title":"Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys","volume":"21","author":"Morrill","year":"2003","journal-title":"Vaccine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/infdis\/jir354","article-title":"Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine","volume":"204","author":"Morrill","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/jir249","article-title":"Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus","volume":"204","author":"Morrill","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/JVI.06190-11","article-title":"Development of a novel nonhuman primate model for Rift Valley fever","volume":"86","author":"Smith","year":"2012","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1128\/JVI.02341-13","article-title":"Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets","volume":"88","author":"Hartman","year":"2014","journal-title":"J. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41541-023-00763-2","article-title":"A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques","volume":"8","author":"Bian","year":"2023","journal-title":"Npj Vaccines"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0035-9203(32)90116-3","article-title":"The infectivity of rift valley fever for monkeys","volume":"26","author":"Findlay","year":"1932","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0035-9203(72)90253-2","article-title":"The pathogenicity of Rift Valley fever virus for the baboon","volume":"66","author":"Davies","year":"1972","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Smith, D.R., Johnston, S.C., Piper, A., Botto, M., Donnelly, G., Shamblin, J., Albari\u00f1o, C.G., Hensley, L.E., Schmaljohn, C., and Nichol, S.T. (2018). Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006474"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41541-022-00476-y","article-title":"Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset","volume":"7","author":"Mooij","year":"2022","journal-title":"Npj Vaccines"},{"key":"ref_87","unstructured":"U.S. Department of Health and Human Services, CDER, and CBER (2015). Product Development under the Animal Rule, FDA."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.3390\/v6072673","article-title":"Challenges, progress, and opportunities: Proceedings of the filovirus medical countermeasures workshop","volume":"6","author":"Hirschberg","year":"2014","journal-title":"Viruses"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Rusnak, J.M., Glass, P.J., Weaver, S.C., Sabourin, C.L., Glenn, A.M., Klimstra, W., Badorrek, C.S., Nasar, F., and Ward, L.A. (2019). Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule. Viruses, 11.","DOI":"10.3390\/v11090807"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JVI.76.1.406-410.2002","article-title":"Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture","volume":"76","author":"Neumann","year":"2002","journal-title":"J. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Ebihara, H., Takada, A., Kobasa, D., Jones, S., Neumann, G., Theriault, S., Bray, M., Feldmann, H., and Kawaoka, Y. (2006). Molecular determinants of Ebola virus virulence in mice. PLoS Pathog., 2.","DOI":"10.1371\/journal.ppat.0020073"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/2049-632X.12157","article-title":"Differences in aerosolization of Rift Valley fever virus resulting from choice of inhalation exposure chamber: Implications for animal challenge studies","volume":"71","author":"Reed","year":"2014","journal-title":"Pathog. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Terasaki, K., Ramirez, S.I., and Makino, S. (2016). Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0005047"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1128\/JVI.02914-13","article-title":"Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH","volume":"88","author":"Kainulainen","year":"2014","journal-title":"J. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virusres.2018.03.005","article-title":"Mutation of adjacent cysteine residues in the NSs protein of Rift Valley fever virus results in loss of virulence in mice","volume":"249","author":"Monteiro","year":"2018","journal-title":"Virus Res."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Borrego, B., and Brun, A. (2020). A Hyper-Attenuated Variant of Rift Valley Fever Virus Generated by a Mutagenic Drug (Favipiravir) Unveils Potential Virulence Markers. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.621463"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Borrego, B., Moreno, S., de la Losa, N., Weber, F., and Brun, A. (2021). The Change P82L in the Rift Valley Fever Virus NSs Protein Confers Attenuation in Mice. Viruses, 13.","DOI":"10.20944\/preprints202101.0439.v1"},{"key":"ref_98","first-page":"253","article-title":"Animal Models of Ebolavirus Infection","volume":"67","author":"Ragland","year":"2017","journal-title":"Comp. Med."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Parish, L.A., Stavale, E.J., Houchens, C.R., and Wolfe, D.N. (2023). Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA). Vaccines, 11.","DOI":"10.3390\/vaccines11061120"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2007.01.046","article-title":"Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease","volume":"362","author":"Bird","year":"2007","journal-title":"Virology"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Morrill, J.C., Ikegami, T., Yoshikawa-Iwata, N., Lokugamage, N., Won, S., Terasaki, K., Zamoto-Niikura, A., Peters, C.J., and Makino, S. (2010). Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA. PLoS ONE, 5.","DOI":"10.1371\/annotation\/326c5f5b-3da9-4b0b-b889-28d4f33d2543"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1038\/s41467-024-49922-6","article-title":"Genetic diversity of 1,845 rhesus macaques improves genetic variation interpretation and identifies disease models","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Taylor, K.L., Lanning, L., Wolfraim, L., Shrivastava Gales, S., Sico, C., Dowling, W.E., Ward, L.A., Florence, W.C., Nuzum, E., and Bryant, P.R. (2022). A U.S. Government-Coordinated Effort to Leverage Non-Human Primate Data to Facilitate Ebolavirus Vaccine Development. Vaccines, 10.","DOI":"10.3390\/vaccines10081201"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","article-title":"Animal models for COVID-19","volume":"586","author":"Dowling","year":"2020","journal-title":"Nature"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/10\/856\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:08:26Z","timestamp":1760112506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/10\/856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":104,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["pathogens13100856"],"URL":"https:\/\/doi.org\/10.3390\/pathogens13100856","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}